|
|
Volumn 69, Issue 15, 2007, Pages 1553-1555
|
|
Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact: An evidence report: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology [3]
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINUCLEAR ANTIBODY;
BETA INTERFERON;
NEUTRALIZING ANTIBODY;
ANTIBODY;
ANTIBODY DETECTION;
ANTIBODY TITER;
CLINICAL PRACTICE;
DRUG EFFECT;
FOLLOW UP;
HUMAN;
LETTER;
MULTIPLE SCLEROSIS;
PRIORITY JOURNAL;
TREATMENT DURATION;
TREATMENT OUTCOME;
CLINICAL TRIAL;
COHORT ANALYSIS;
DRUG ANTAGONISM;
DRUG RESISTANCE;
EVIDENCE BASED MEDICINE;
IMMUNOLOGY;
NOTE;
PRACTICE GUIDELINE;
REPRODUCIBILITY;
STANDARD;
TREATMENT FAILURE;
ANTIBODIES;
CLINICAL TRIALS AS TOPIC;
COHORT STUDIES;
DRUG RESISTANCE;
EVIDENCE-BASED MEDICINE;
INTERFERON-BETA;
MULTIPLE SCLEROSIS;
PRACTICE GUIDELINES AS TOPIC;
REPRODUCIBILITY OF RESULTS;
TREATMENT FAILURE;
|
|
EID: 35148870596
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/01.wnl.0000295671.79239.f1 Document Type: Letter |
|
Times cited : (4)
|
|
References (3)
|
